Zhouping Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhouping Wang has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Wei Li
Department of Cardiology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
5 shared publicationsYanfei Wang
Department of Cardiology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
5 shared publicationsXiaofei Xie
Department of Cardiology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
4 shared publications- Xiaoqiong Gu
Department of Clinical Biological Resource Bank Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou People's Republic of China
4 shared publications Jia Yuan
Department of Pediatric Cardiology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, China
3 shared publicationsLi Zhang
Department of Cardiology, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
3 shared publications
Latest Publications
- 1 June 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (6) , 452
Higher IVIG resistance in Kawasaki disease patients treated early after fever onset: a single-center retrospective study of 2,988 cases
To investigate the impact of intravenous immunoglobulin (IVIG) timing on coronary artery outcomes and treatment response in children with Kawasaki disease (KD). This retrospective study analyzed 2,988 pediatric patients with Kawasaki disease (KD) who received initial IVIG treatment within 3–7 days of fever onset. Patients were categorized by IVIG initiation time: Group A (day 3 of fever, n = 134), Group B (day 4 of fever, n = 465), Group C (day 5 of fever, n = 1101), Group D (day 6 of fever, n = 833), and Group E (day 7 of fever, n = 455). We compared baseline characteristics, IVIG resistance, and convalescent-phase coronary artery lesions (CALs). Multivariate logistic regression analyzed the association between early initiation (days 3–4 of fever) of initial IVIG therapy and IVIG resistance or convalescent-phase CALs. Propensity score matching (PSM) was used to match the early (days 3–4 of fever, n = 590) and conventional (days 5–7 of fever, n = 590) treatment groups. Baseline data during the acute phase revealed that with delayed initiation of initial IVIG treatment, serum albumin (ALB), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels in children with KD showed a significant overall decreasing trend (P < 0.001), while platelet (PLT) counts and the incidence of acute-phase CALs showed a significant overall increase (P < 0.001). However, no significant difference was found in convalescent-phase CALs incidence among groups. IVIG resistance was more common among children who required early treatment (P < 0.001). PSM analysis showed no significant difference in acute or convalescent-phase CALs between the early and conventional groups. In the multivariate logistic regression analysis after adjusting for confounders, early IVIG initiation was not significantly associated with convalescent-phase CALs but was associated with a significantly increased risk of IVIG resistance (OR: 1.74; 95% CI: 1.32–2.29; P < 0.001). Conclusion: In this single-center retrospective study, initiating initial IVIG therapy within 3–7 days of fever onset showed no significant impact on the incidence of convalescent-phase CALs at different treatment timings. However, IVIG resistance was more common among children who required early treatment (days 3–4 of fever). Due to potential residual confounding by indication, these findings represent a non-causal association that may reflect differences in underlying disease severity and clinical presentation. Future prospective, multicenter, randomized controlled trials are needed to further clarify the optimal timing of initial IVIG therapy in KD patients, thereby providing evidence for developing individualized treatment strategies and improving long-term prognosis. What is Known: • Intravenous immunoglobulin (IVIG) is the first-line standard therapy for Kawasaki disease (KD), effectively reducing coronary artery lesions (CALs) and improving clinical prognosis. Initial IVIG timing is closely linked to treatment response and coronary outcomes in KD, but the optimal initiation window remains unclear, and large-sample evidence on early IVIG's impact on resistance and long-term CALs is insufficient. What is New: • In this large retrospective cohort, IVIG initiation at 3 -7 days post fever onset had no significant effect on convalescent-phase CALs in KD patients. Early IVIG administration (on days 3-4 of fever) independently increased IVIG resistance risk, likely reflecting baseline disease severity, warranting further multicenter prospective trials for optimal timing.
- 1 June 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (6) , 452
Higher IVIG resistance in Kawasaki disease patients treated early after fever onset: a single-center retrospective study of 2,988 cases
To investigate the impact of intravenous immunoglobulin (IVIG) timing on coronary artery outcomes and treatment response in children with Kawasaki disease (KD). This retrospective study analyzed 2,988 pediatric patients with Kawasaki disease (KD) who received initial IVIG treatment within 3–7 days of fever onset. Patients were categorized by IVIG initiation time: Group A (day 3 of fever, n = 134), Group B (day 4 of fever, n = 465), Group C (day 5 of fever, n = 1101), Group D (day 6 of fever, n = 833), and Group E (day 7 of fever, n = 455). We compared baseline characteristics, IVIG resistance, and convalescent-phase coronary artery lesions (CALs). Multivariate logistic regression analyzed the association between early initiation (days 3–4 of fever) of initial IVIG therapy and IVIG resistance or convalescent-phase CALs. Propensity score matching (PSM) was used to match the early (days 3–4 of fever, n = 590) and conventional (days 5–7 of fever, n = 590) treatment groups. Baseline data during the acute phase revealed that with delayed initiation of initial IVIG treatment, serum albumin (ALB), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels in children with KD showed a significant overall decreasing trend (P < 0.001), while platelet (PLT) counts and the incidence of acute-phase CALs showed a significant overall increase (P < 0.001). However, no significant difference was found in convalescent-phase CALs incidence among groups. IVIG resistance was more common among children who required early treatment (P < 0.001). PSM analysis showed no significant difference in acute or convalescent-phase CALs between the early and conventional groups. In the multivariate logistic regression analysis after adjusting for confounders, early IVIG initiation was not significantly associated with convalescent-phase CALs but was associated with a significantly increased risk of IVIG resistance (OR: 1.74; 95% CI: 1.32–2.29; P < 0.001). Conclusion: In this single-center retrospective study, initiating initial IVIG therapy within 3–7 days of fever onset showed no significant impact on the incidence of convalescent-phase CALs at different treatment timings. However, IVIG resistance was more common among children who required early treatment (days 3–4 of fever). Due to potential residual confounding by indication, these findings represent a non-causal association that may reflect differences in underlying disease severity and clinical presentation. Future prospective, multicenter, randomized controlled trials are needed to further clarify the optimal timing of initial IVIG therapy in KD patients, thereby providing evidence for developing individualized treatment strategies and improving long-term prognosis. What is Known: • Intravenous immunoglobulin (IVIG) is the first-line standard therapy for Kawasaki disease (KD), effectively reducing coronary artery lesions (CALs) and improving clinical prognosis. Initial IVIG timing is closely linked to treatment response and coronary outcomes in KD, but the optimal initiation window remains unclear, and large-sample evidence on early IVIG's impact on resistance and long-term CALs is insufficient. What is New: • In this large retrospective cohort, IVIG initiation at 3 -7 days post fever onset had no significant effect on convalescent-phase CALs in KD patients. Early IVIG administration (on days 3-4 of fever) independently increased IVIG resistance risk, likely reflecting baseline disease severity, warranting further multicenter prospective trials for optimal timing.
- Open Access
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1807028
Predicting coronary artery lesions in patients with Kawasaki disease in China using a machine-learning algorithm: a retrospective cohort study
Background: This study aimed to analyze the risk factors of coronary artery lesions (CAL) in patients with Kawasaki disease (KD) and establish predictive models for CAL in patients with KD. Methods: This retrospective cohort study included KD patients admitted to Shengjing Hospital of China Medical University, collecting data on 41 demographic, clinical, and laboratory parameters. LASSO regression identified key predictive variables. The dataset was split into 70% training and 30% validation. Ten models were trained using 10-fold cross-validation, with the training set balanced through ROSE oversampling. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Results: The CatBoost algorithm achieved the best results: AUC, 0.953; sensitivity, 0.908; specificity, 0.860; and accuracy, 0.883. Internal validation results were as follows: AUC, 0.874; sensitivity, 0.721; specificity, 0.848; accuracy, 0.837. External validation results were as follows: AUC, 0.876.sensitivity, 0.894; specificity, 0.954. Conclusions: We present a machine-learning model that predicts the risk of CAL in patients with KD in China, aiding doctors in creating personalized treatment strategies to improve outcomes.
- 22 April 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1807028
Open AccessPredicting coronary artery lesions in patients with Kawasaki disease in China using a machine-learning algorithm: a retrospective cohort study
Background: This study aimed to analyze the risk factors of coronary artery lesions (CAL) in patients with Kawasaki disease (KD) and establish predictive models for CAL in patients with KD. Methods: This retrospective cohort study included KD patients admitted to Shengjing Hospital of China Medical University, collecting data on 41 demographic, clinical, and laboratory parameters. LASSO regression identified key predictive variables. The dataset was split into 70% training and 30% validation. Ten models were trained using 10-fold cross-validation, with the training set balanced through ROSE oversampling. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Results: The CatBoost algorithm achieved the best results: AUC, 0.953; sensitivity, 0.908; specificity, 0.860; and accuracy, 0.883. Internal validation results were as follows: AUC, 0.874; sensitivity, 0.721; specificity, 0.848; accuracy, 0.837. External validation results were as follows: AUC, 0.876.sensitivity, 0.894; specificity, 0.954. Conclusions: We present a machine-learning model that predicts the risk of CAL in patients with KD in China, aiding doctors in creating personalized treatment strategies to improve outcomes.
- Open Access
- 6 February 2026
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (5) , 556-564
Characterization of the oral microbiota of Kawasaki disease patients by metagenomic analysis: A pilot study
- 6 February 2026
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (5) , 556-564
Open AccessCharacterization of the oral microbiota of Kawasaki disease patients by metagenomic analysis: A pilot study
- Open Access
- 22 January 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1741197
A nomogram for predicting the risk of persistent coronary artery aneurysms in children with Kawasaki disease: a retrospective study
Objective: To develop and validate a nomogram for the individualized prediction of persistent coronary artery aneurysms (CAAs) in children with Kawasaki disease (KD) who have developed CAAs in the acute phase. Methods: This retrospective cohort study enrolled children diagnosed with KD and complicated by CAA between September 2015 and December 2023. The primary outcome was defined as the persistence of CAA 90 days after disease onset. Predictor selection was performed using 1,000 bootstrap resamples combined with LASSO regression for stability. A predictive model was constructed using multivariate logistic regression. The model's discrimination, calibration, and clinical utility were assessed by the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). Results: A total of 135 children were included, of whom 80 (59.3%) had persistent CAAs. Stability selection identified the maximum coronary artery Z -score (ZM), age < 12 months (Age1), and total bile acid (TBA) as key predictors. The parsimonious model (Model B) built on these predictors demonstrated excellent performance, with an optimism-corrected AUC of 0.933 (95% CI: 0.905–0.960). It was well-calibrated, and DCA showed a positive net benefit across a wide threshold probability range of 5%–100%. Conclusion: This study successfully developed a nomogram based on ZM, Age1, and TBA. This tool can effectively identify KD children at risk of persistent CAAs, providing an intuitive and quantitative decision-making aid for precise risk stratification and optimized long-term management in this high-risk population.
- 22 January 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1741197
Open AccessA nomogram for predicting the risk of persistent coronary artery aneurysms in children with Kawasaki disease: a retrospective study
Objective: To develop and validate a nomogram for the individualized prediction of persistent coronary artery aneurysms (CAAs) in children with Kawasaki disease (KD) who have developed CAAs in the acute phase. Methods: This retrospective cohort study enrolled children diagnosed with KD and complicated by CAA between September 2015 and December 2023. The primary outcome was defined as the persistence of CAA 90 days after disease onset. Predictor selection was performed using 1,000 bootstrap resamples combined with LASSO regression for stability. A predictive model was constructed using multivariate logistic regression. The model's discrimination, calibration, and clinical utility were assessed by the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA). Results: A total of 135 children were included, of whom 80 (59.3%) had persistent CAAs. Stability selection identified the maximum coronary artery Z -score (ZM), age < 12 months (Age1), and total bile acid (TBA) as key predictors. The parsimonious model (Model B) built on these predictors demonstrated excellent performance, with an optimism-corrected AUC of 0.933 (95% CI: 0.905–0.960). It was well-calibrated, and DCA showed a positive net benefit across a wide threshold probability range of 5%–100%. Conclusion: This study successfully developed a nomogram based on ZM, Age1, and TBA. This tool can effectively identify KD children at risk of persistent CAAs, providing an intuitive and quantitative decision-making aid for precise risk stratification and optimized long-term management in this high-risk population.
- Open Access
- 19 December 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1733982
Predictive value of aneurysm characteristics for one-year persistence in Kawasaki disease: a retrospective cohort study
Objective: While systemic factors influence Kawasaki disease outcomes, this study specifically determines the independent and incremental prognostic value of the coronary aneurysm's own characteristics—maximum Z -score (ZM), morphology, and Location—for predicting persistence one year after onset. Methods: This retrospective cohort study enrolled 135 children with KD and coronary artery aneurysms (CAA). We analyzed the maximum Z -score (ZM), morphology (fusiform/saccular), and coronary artery Location (Left/Right/Bilateral) of the index aneurysm (the largest by Z -score). Univariable and multivariable logistic regression were used to identify independent predictors. The predictive performance of a model containing only ZM was compared to that of the Comprehensive Aneurysm Characteristic (CAC) model, which incorporates ZM, morphology, and Location, by assessing the area under the receiver operating characteristic curve (AUC). A descriptive analysis was additionally performed on a high-risk subgroup defined by a ZM ≥ 5.0. Results: The early ZM was a strong predictor of persistent coronary aneurysms at one year (OR = 4.925, P < 0.001), with an AUC of 0.909. In the multivariable analysis, larger ZM (aOR = 6.775, 95% CI: 3.133–14.648, P < 0.001), saccular morphology (aOR = 7.648, 95% CI: 1.428–40.967, P < 0.05), and LAD involvement (aOR = 4.304, 95% CI: 1.163–15.928, P < 0.05) emerged as independent predictors. The CAC model demonstrated a statistically significant improvement in predictive ability over the ZM-only model (AUC: 0.941 vs. 0.909, P = 0.025). Exploratory analysis of the high-risk subgroup (ZM ≥ 5.0) revealed a markedly higher prevalence of saccular morphology in patients with persistent aneurysms, suggesting it may serve as a crucial risk signal independent of absolute size in this population. The CAC model also showed excellent calibration and superior clinical utility across a wide range of decision thresholds. Conclusion: The intrinsic characteristics of a coronary aneurysm—its size, shape, and distribution—collectively provide powerful, independent prediction of its persistence at one year. The strong association of specific morphological features with persistence in the high-risk subgroup underscores the value of anatomy-based assessment for refining risk stratification, complementing evaluations based on systemic host factors.
- 19 December 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1733982
Open AccessPredictive value of aneurysm characteristics for one-year persistence in Kawasaki disease: a retrospective cohort study
Objective: While systemic factors influence Kawasaki disease outcomes, this study specifically determines the independent and incremental prognostic value of the coronary aneurysm's own characteristics—maximum Z -score (ZM), morphology, and Location—for predicting persistence one year after onset. Methods: This retrospective cohort study enrolled 135 children with KD and coronary artery aneurysms (CAA). We analyzed the maximum Z -score (ZM), morphology (fusiform/saccular), and coronary artery Location (Left/Right/Bilateral) of the index aneurysm (the largest by Z -score). Univariable and multivariable logistic regression were used to identify independent predictors. The predictive performance of a model containing only ZM was compared to that of the Comprehensive Aneurysm Characteristic (CAC) model, which incorporates ZM, morphology, and Location, by assessing the area under the receiver operating characteristic curve (AUC). A descriptive analysis was additionally performed on a high-risk subgroup defined by a ZM ≥ 5.0. Results: The early ZM was a strong predictor of persistent coronary aneurysms at one year (OR = 4.925, P < 0.001), with an AUC of 0.909. In the multivariable analysis, larger ZM (aOR = 6.775, 95% CI: 3.133–14.648, P < 0.001), saccular morphology (aOR = 7.648, 95% CI: 1.428–40.967, P < 0.05), and LAD involvement (aOR = 4.304, 95% CI: 1.163–15.928, P < 0.05) emerged as independent predictors. The CAC model demonstrated a statistically significant improvement in predictive ability over the ZM-only model (AUC: 0.941 vs. 0.909, P = 0.025). Exploratory analysis of the high-risk subgroup (ZM ≥ 5.0) revealed a markedly higher prevalence of saccular morphology in patients with persistent aneurysms, suggesting it may serve as a crucial risk signal independent of absolute size in this population. The CAC model also showed excellent calibration and superior clinical utility across a wide range of decision thresholds. Conclusion: The intrinsic characteristics of a coronary aneurysm—its size, shape, and distribution—collectively provide powerful, independent prediction of its persistence at one year. The strong association of specific morphological features with persistence in the high-risk subgroup underscores the value of anatomy-based assessment for refining risk stratification, complementing evaluations based on systemic host factors.
- Open Access
- 26 November 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1629600
A machine learning algorithm to predict treatment effectiveness for Kawasaki disease in China: a retrospective model development and validation study
Background: Kawasaki disease (KD) is the primary cause of acquired heart disease in children. Intravenous immunoglobulin (IVIG) is the first-line therapy for KD; however, IVIG resistance can occur. Reliable treatment efficacy prediction tools for Chinese patients are lacking, which this study aimed to address. Methods: This retrospective cohort study enrolled patients diagnosed with KD admitted to Shengjing Hospital of China Medical University and collected data on 36 demographic, clinical, and laboratory parameters. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to identify key predictive variables. The dataset was divided into training (70%) and validation (30%) sets. Ten models were trained through 10-fold cross-validation, and the training set data were balanced using the ROSE method for oversampling. The performance of each model was evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Patients with KD admitted to Guangzhou Women and Children’s Medical Centre, Guangzhou Medical University, between January 2023 and December 2024 were enrolled as an external validation cohort. Results: The CatBoost machine learning algorithm achieved the best comprehensive results (AUC: 0·960; sensitivity: 0·883; specificity: 0·889, and accuracy: 0·887). The internal validation results with CatBoost were AUC: 0·862; 95% confidence interval [CI]: 0·6453–0·7651; sensitivity: 0·716; specificity: 0·877; and accuracy: 0·861. The external validation results were AUC: 0·834; 95% CI: 0·783–0·884; sensitivity: 0·817; specificity: 0·838, and accuracy: 0·835. Conclusions: We present a machine learning model that can predict the risk of IVIG non-responsiveness in patients with KD in China. This model may help doctors develop personalized treatment strategies, thus improving the prognosis of KD.
- 26 November 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1629600
Open AccessA machine learning algorithm to predict treatment effectiveness for Kawasaki disease in China: a retrospective model development and validation study
Background: Kawasaki disease (KD) is the primary cause of acquired heart disease in children. Intravenous immunoglobulin (IVIG) is the first-line therapy for KD; however, IVIG resistance can occur. Reliable treatment efficacy prediction tools for Chinese patients are lacking, which this study aimed to address. Methods: This retrospective cohort study enrolled patients diagnosed with KD admitted to Shengjing Hospital of China Medical University and collected data on 36 demographic, clinical, and laboratory parameters. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to identify key predictive variables. The dataset was divided into training (70%) and validation (30%) sets. Ten models were trained through 10-fold cross-validation, and the training set data were balanced using the ROSE method for oversampling. The performance of each model was evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Patients with KD admitted to Guangzhou Women and Children’s Medical Centre, Guangzhou Medical University, between January 2023 and December 2024 were enrolled as an external validation cohort. Results: The CatBoost machine learning algorithm achieved the best comprehensive results (AUC: 0·960; sensitivity: 0·883; specificity: 0·889, and accuracy: 0·887). The internal validation results with CatBoost were AUC: 0·862; 95% confidence interval [CI]: 0·6453–0·7651; sensitivity: 0·716; specificity: 0·877; and accuracy: 0·861. The external validation results were AUC: 0·834; 95% CI: 0·783–0·884; sensitivity: 0·817; specificity: 0·838, and accuracy: 0·835. Conclusions: We present a machine learning model that can predict the risk of IVIG non-responsiveness in patients with KD in China. This model may help doctors develop personalized treatment strategies, thus improving the prognosis of KD.
- 22 October 2025
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery aneurysms
Paediatric Rheumatology; Authors: W. Li, Y. Tong, X. Xue, L. Su, Y.-J. Wu, X. Xie, Y. Wang, M. Tang, H. Zhang, L. Hu, F. Wang, X. Gu, Z. Wang
- 22 October 2025
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery aneurysms
Paediatric Rheumatology; Authors: W. Li, Y. Tong, X. Xue, L. Su, Y.-J. Wu, X. Xie, Y. Wang, M. Tang, H. Zhang, L. Hu, F. Wang, X. Gu, Z. Wang
- Open Access
- 29 August 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (10) , 1-11
Wedelolactone induces pyroptosis to suppress retinoblastoma by inhibiting the Nrf2/Keap1 signaling pathway
Background Retinoblastoma is an intraocular malignancy with limited therapeutic options, imposing a severe health burden on young patients. Wedelolactone (WDL), a natural product from E. prostrata, possesses an anti-retinoblastoma activity, with the underlying regulatory mechanism remaining unknown. Methods Retinoblastoma cell lines and xenograft nude mouse models were treated with WDL and RTA-408, an agonist for nuclear factor-erythroid 2-related factor 2 (Nrf2). Western blotting was conducted to determine the protein expression levels of kelch-like ECH-associated protein 1 (Keap1) and Nrf2. We performed the cell counting kit-8 assay, the 5-ethynyl-2-deoxyuridine staining, and flow cytometry to detect cell viability, proliferation, and apoptosis, respectively. The tumor progression in vivo was evaluated via the measurement of volume, weight, and proliferation levels of solid tumors. Monosodium urate crystal was applied to activate pyroptosis which was assessed by the expression detection of pyroptosis-related indicators. Results WDL treatment elevated the expression of Keap1 and reduced the level of Nrf2. RTA-408 suppressed WDL-induced pyroptosis of retinoblastoma cells and reversed the effect of WDL on inhibiting retinoblastoma cell proliferation, promoting tumor cell apoptosis, and repressing the growth of solid tumors of the xenograft models. In addition, monosodium urate-induced pyroptosis partially restored the anti-retinoblastoma effect of WDL impaired by RTA-408. Conclusion WDL triggers pyroptosis by inhibiting the Nrf2/Keap1 signaling pathway to exert anti-retinoblastoma effects.
- 29 August 2025
- Published by Springer Nature in Medical Oncology
- Vol. 42 (10) , 1-11
Open AccessWedelolactone induces pyroptosis to suppress retinoblastoma by inhibiting the Nrf2/Keap1 signaling pathway
Background Retinoblastoma is an intraocular malignancy with limited therapeutic options, imposing a severe health burden on young patients. Wedelolactone (WDL), a natural product from E. prostrata, possesses an anti-retinoblastoma activity, with the underlying regulatory mechanism remaining unknown. Methods Retinoblastoma cell lines and xenograft nude mouse models were treated with WDL and RTA-408, an agonist for nuclear factor-erythroid 2-related factor 2 (Nrf2). Western blotting was conducted to determine the protein expression levels of kelch-like ECH-associated protein 1 (Keap1) and Nrf2. We performed the cell counting kit-8 assay, the 5-ethynyl-2-deoxyuridine staining, and flow cytometry to detect cell viability, proliferation, and apoptosis, respectively. The tumor progression in vivo was evaluated via the measurement of volume, weight, and proliferation levels of solid tumors. Monosodium urate crystal was applied to activate pyroptosis which was assessed by the expression detection of pyroptosis-related indicators. Results WDL treatment elevated the expression of Keap1 and reduced the level of Nrf2. RTA-408 suppressed WDL-induced pyroptosis of retinoblastoma cells and reversed the effect of WDL on inhibiting retinoblastoma cell proliferation, promoting tumor cell apoptosis, and repressing the growth of solid tumors of the xenograft models. In addition, monosodium urate-induced pyroptosis partially restored the anti-retinoblastoma effect of WDL impaired by RTA-408. Conclusion WDL triggers pyroptosis by inhibiting the Nrf2/Keap1 signaling pathway to exert anti-retinoblastoma effects.
- 19 March 2024
- Published by Elsevier in American Heart Journal
- Vol. 273, 1-9
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial
- 19 March 2024
- Published by Elsevier in American Heart Journal
- Vol. 273, 1-9
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial